Huber Needles Market, Product Type (Curved Huber Needles, Straight Huber Needles), By Application (Dialysis, Blood Transfusions, IV Cancer Application, Lap-band Adjustments, Home Parenteral Nutrition, Others), By End User (Hospitals, Oncology Centers, Clinics, Ambulatory Surgical Centers, Home Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Mar 2020

Code : CMI3648

Pages :135

Formats :

Excel and PDF

Industry : Medical Devices

Huber Needles MarketSize and Trends

Statistics:

The global Huber needles market is estimated to account for US$ 66.1 Mn in terms of value and 51,270,030 Units in terms of volume by the end of 2027.

IV Cancer Application segment in the global Huber needles market was valued at US$ 16.8 Mn in 2019 and is expected to reach US$ 29.4 Mn by 2027 at a CAGR of 7.2% during the forecast period.

Market Trends/Key Takeaways

Increasing focus on reducing needle stick injuries has led companies to develop and introduce various needles with enhanced safety features in the market. Products with advanced features such as self-retracting needles and needles with safety locking are gaining traction among healthcare professionals and patients.

Moreover, high prevalence of HIV and blood-borne diseases has also led manufacturers to develop safe needles. For instance, according to Joint United Nations Program on HIV/AIDS, 37.9 million people globally were living with HIV at the end of 2018.

Increasing prevalence of end-stage renal disease is expected to boost growth of the global Huber needles market. For instance, according to November 2019 data of National Center for Biotechnology Information, the prevalence of end-stage renal disease is rising at a stable number of about 20,000 cases per year.

Major players in the market are focused on adopting various marketing strategies to expand their customer base. For instance, in February 2020, Baxter International Inc. presented at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y.